🔗 Share this article

This year's prestigious award in Physiology or Medicine has been granted for transformative findings that clarify how the immune system targets dangerous pathogens while sparing the body's own cells.

Three renowned researchers—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this honor.

The work uncovered unique "sentinels" within the immune system that remove rogue immune cells that could attacking the organism.

These findings are now enabling new treatments for immune disorders and malignancies.

The laureates will share a monetary award valued at 11 million Swedish kronor.

Crucial Discoveries

"Their research has been essential for comprehending how the body's defenses operates and the reason we do not all develop severe self-attack conditions," stated the chair of the award panel.

The trio's studies explain a core mystery: How does the immune system defend us from numerous invaders while keeping our own tissues unharmed?

Our immune system employs white blood cells that scan for indicators of infection, including pathogens and germs it has not met before.

These cells employ sensors—called recognition units—that are generated by chance in countless variations.

That provides the immune system the ability to fight a broad range of threats, but the randomness of the process inevitably creates white blood cells that may target the body.

Security Guards of the Body

Scientists earlier knew that some of these problematic white blood cells were eliminated in the immune organ—where white blood cells mature.

This year's award honors the discovery of T-reg cells—known as the immune system's "security guards"—which patrol the body to disarm other defenders that attack the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, MS, and RA.

The prize committee stated, "The findings have laid the foundation for a novel area of investigation and accelerated the creation of new treatments, for instance for cancer and autoimmune diseases."

In malignancies, T-regs block the body from fighting the growth, so studies are aimed at lowering their quantity.

In autoimmune diseases, experiments are testing increasing T-reg cells so the organism is no longer under attack. A similar approach could also be useful in minimizing the chances of organ transplant failure.

Pioneering Studies

Professor Shimon Sakaguchi, from Osaka University, performed tests on rodents that had their thymus extracted, leading to self-attack conditions.

He showed that introducing immune cells from healthy animals could stop the disease—implying there was a system for blocking defenders from attacking the host.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in rodents and humans that led to the identification of a gene vital for how regulatory T-cells operate.

"Their pioneering research has revealed how the immune system is kept in check by T-reg cells, stopping it from accidentally targeting the body's own tissues," said a leading physiology specialist.

"The research is a remarkable example of how basic biological research can have broad implications for public health."